Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
29.68
+0.34 (1.16%)
Nov 19, 2024, 4:00 PM EST - Market closed
Dyne Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 532.16 | 121.63 | 172.15 | 200.83 | 300.85 | 14.63 | Upgrade
|
| Short-Term Investments | 191.51 | 1.47 | 83.87 | 175.75 | 44.46 | - | Upgrade
|
| Cash & Short-Term Investments | 723.67 | 123.1 | 256.01 | 376.57 | 345.31 | 14.63 | Upgrade
|
| Cash Growth | 358.54% | -51.92% | -32.01% | 9.05% | 2259.99% | 80.11% | Upgrade
|
| Prepaid Expenses | 12.72 | 6.28 | 9.58 | 5.44 | 3.77 | 0.13 | Upgrade
|
| Restricted Cash | - | - | - | 0.38 | - | - | Upgrade
|
| Total Current Assets | 736.39 | 129.38 | 265.59 | 382.39 | 349.09 | 14.76 | Upgrade
|
| Property, Plant & Equipment | 30.52 | 33.39 | 38.41 | 40.96 | 1.95 | 1.49 | Upgrade
|
| Other Long-Term Assets | 1.94 | 2.32 | 2.32 | 2.31 | 2.3 | 0.19 | Upgrade
|
| Total Assets | 768.84 | 165.08 | 306.33 | 425.66 | 353.33 | 16.44 | Upgrade
|
| Accounts Payable | 6.16 | 22.94 | 5.26 | 4.03 | 3.44 | 1.26 | Upgrade
|
| Accrued Expenses | 32.29 | 23.44 | 18.22 | 20.74 | 7.48 | 1.08 | Upgrade
|
| Current Portion of Leases | 4.81 | 4.72 | 4.61 | 3.89 | - | - | Upgrade
|
| Other Current Liabilities | - | - | 0 | 0.06 | 0.05 | 0.02 | Upgrade
|
| Total Current Liabilities | 43.26 | 51.1 | 28.09 | 28.72 | 10.97 | 2.36 | Upgrade
|
| Long-Term Leases | 20.04 | 22.7 | 25.87 | 28.74 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 0.04 | Upgrade
|
| Total Liabilities | 63.3 | 73.79 | 53.96 | 57.47 | 10.97 | 2.4 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,565 | 723.8 | 649.5 | 596.93 | 421.57 | 6.35 | Upgrade
|
| Retained Earnings | -860.39 | -632.51 | -396.57 | -228.47 | -79.18 | -19.75 | Upgrade
|
| Comprehensive Income & Other | 0.48 | - | -0.57 | -0.27 | -0.03 | - | Upgrade
|
| Total Common Equity | 705.54 | 91.29 | 252.36 | 368.2 | 342.37 | -13.39 | Upgrade
|
| Shareholders' Equity | 705.54 | 91.29 | 252.36 | 368.2 | 342.37 | 14.04 | Upgrade
|
| Total Liabilities & Equity | 768.84 | 165.08 | 306.33 | 425.66 | 353.33 | 16.44 | Upgrade
|
| Total Debt | 24.86 | 27.42 | 30.48 | 32.64 | - | - | Upgrade
|
| Net Cash (Debt) | 698.82 | 95.69 | 225.53 | 343.94 | 345.31 | 14.63 | Upgrade
|
| Net Cash Growth | 439.23% | -57.57% | -34.43% | -0.40% | 2259.99% | 208.11% | Upgrade
|
| Net Cash Per Share | 8.32 | 1.60 | 4.34 | 6.76 | 23.99 | 5.99 | Upgrade
|
| Filing Date Shares Outstanding | 101.77 | 81.96 | 56.34 | 51.6 | 51.46 | 2.59 | Upgrade
|
| Total Common Shares Outstanding | 101.75 | 61.47 | 55.63 | 51.53 | 45.45 | 2.59 | Upgrade
|
| Working Capital | 693.13 | 78.28 | 237.51 | 353.67 | 338.12 | 12.4 | Upgrade
|
| Book Value Per Share | 6.93 | 1.49 | 4.54 | 7.15 | 7.53 | -5.18 | Upgrade
|
| Tangible Book Value | 705.54 | 91.29 | 252.36 | 368.2 | 342.37 | -13.39 | Upgrade
|
| Tangible Book Value Per Share | 6.93 | 1.49 | 4.54 | 7.15 | 7.53 | -5.18 | Upgrade
|
| Machinery | 10.96 | 9.64 | 8.67 | 5.2 | 2.82 | 1.77 | Upgrade
|
| Construction In Progress | 0.45 | 0.43 | 0.91 | 1.46 | 0.11 | - | Upgrade
|
| Leasehold Improvements | - | - | - | - | 0.01 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.